Sleep and Light Therapy for Circadian Rhythm Disorder
(CARRS-P2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how changes in sleep and light exposure affect the brain's reward system in teenagers, particularly those with late bedtimes. Researchers seek to determine if interventions such as adjusting sleep schedules, reducing evening blue light, and increasing morning light (morning light therapy) can improve sleep and potentially reduce the risk of substance use. Participants will either adopt a new sleep and light routine or maintain their current habits for comparison. Teens with a regular school schedule and a usual bedtime after 11:15 PM may be well-suited for this study. As an unphased study, this trial offers a unique opportunity to contribute to understanding how lifestyle changes can benefit teen health.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but it excludes those who have changed their psychotropic medications in the 2 weeks before joining or plan major changes during the study. It also excludes those on medications that increase sensitivity to blue light.
What prior data suggests that these treatments are safe for adolescents?
Research shows that wearing blue blocker goggles in the evening can improve sleep quality. Excessive blue light at night disrupts sleep patterns, but blocking this light helps maintain the body's internal clock.
Bright light exposure in the morning is also part of the treatment. Studies have found that morning light therapy can adjust sleep schedules, making it easier to wake up and stay alert during the day.
Researchers will monitor participants' sleep, mood, and any substance use to track changes and assess the treatment's effectiveness, providing a better understanding of its impact on sleep and overall health.
Adjusting the sleep schedule can also be beneficial. Setting specific times to go to bed and wake up aims to create a regular sleep pattern that supports better rest and daily functioning.
Overall, treatments in this trial are well-tolerated and have shown positive effects on sleep patterns in previous studies. They are generally considered safe when used as directed.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores an innovative approach to managing Circadian Rhythm Disorder by combining light therapy and sleep scheduling. Unlike traditional treatments that may focus on medications or general sleep hygiene practices, this method specifically manipulates light exposure and sleep timing to reset the body's internal clock. The use of blue blocker goggles in the evening and bright light goggles in the morning offers a novel way to control the light spectrum and intensity, potentially leading to faster and more natural adjustments to sleep patterns. By leveraging technology to monitor sleep, mood, and substance use, this approach provides a holistic view of the impact on daily life, offering insights that could lead to more personalized and effective treatments.
What evidence suggests that this trial's treatments could be effective for circadian rhythm disorder?
This trial will compare different methods for managing circadian rhythm disorders. Research has shown that reducing blue light exposure in the evening, as participants in the "Advance/Extend Manipulation" arm will do, can improve sleep quality and duration by maintaining the body's internal clock. Blue light can interfere with melatonin, a hormone that aids sleep. Participants in this arm will also increase morning bright light exposure, which can reset the natural sleep-wake cycle and enhance sleep quality. Adjusting the sleep schedule by changing bedtime and wake-up time is another method tested in this trial to align the body's clock with natural light patterns. Together, these methods have been found to improve sleep and may help with sleep disorders related to the body's internal clock.12678
Who Is on the Research Team?
Brant Hasler, PhD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for healthy teens typically enrolled in high school, who go to bed later than 11:15 PM and are not homeschooled. They can't have metal in their body, be pregnant, have unstable medical conditions, recent changes to psychotropic meds, extreme late sleep patterns, frequent headaches or migraines, a history of substance use or serious psychiatric disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Observational Study
Participants undergo 2 weeks of home sleep monitoring followed by an overnight laboratory visit for assessments
Experimental Manipulation
Participants in the Late group undergo sleep and circadian rhythm manipulation for approximately 2 weeks
Follow-up
Participants are monitored for changes in sleep and substance use every 6 months
What Are the Treatments Tested in This Trial?
Interventions
- Decrease evening blue light
- Increase morning bright light
- Monitor sleep, mood, and substance use
- Sleep Scheduling
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator